30th Annual Clinical Update for the Comprehensive Ophthalmologist

The Texas Tech University Health Sciences Center (TTUHSC) Department of Ophthalmology and Visual Sciences will host the 30th Annual Clinical Update for the Comprehensive Ophthalmologist from 7:30 a.m. to 5:15 p.m. June 28 at the Overton Hotel and Conference Center Horizon Ballroom, 2322 Mac Davis Lane.

The purpose of the conference is to provide ophthalmologists with current and emerging surgical techniques, treatments and medications for diseases and disorders of the eye. Learning objectives will include: recognizing and recommending further evaluation and treatment options for patients, including when to refer to other specialists in ophthalmology and developing patient-centered, evidence-based evaluation and treatment plans.

Presentations and speakers include:

  • Clinical Research: Why Me, Why Now?
    Wade A. Graham, M.D.
  • Endophthalmitis — What’s New Locally and Globally
    Mark T. Goulas, M.D.
  • Cornea and Refractive Surgery, Transepithelial Phototherapeutic Keratectomy Guided by Optical Coherence Tomography Imaging
    Sloan W. Rush, M.D.
  • New Options for the Management of Corneal Ectasia
    Walter Beebee, M.D.
  • Amniotic Membrane: The Cover Up
    William W. Yang, M.D.
  • Retina, Vitritis in a Healthy 18-Year-Old Male: What’s Next?
    Michel J. Shami, M.D.
  • Management of Retained Lens Fragments Following Cataract Extraction
    Lina M. Marouf, M.D.
  • Conclusions from the Comparison of Age-related Macular Degeneration Treatments Trial
    Joel George, M.D.
  • Mechanism of Macular Hole Closure
    Sunil S. Patel, M.D.
  • Current Concepts in the Management of Oculoplastics Disorders
    Jorge Corona, M.D.
  • Emerging Trends and Paradigm Shifts in Glaucoma Management
    Craig J. Chaya, M.D. and John Kim, M.D.
  • Ethics, Collegial Relationships and Communication
    George R. Beauchamp, M.D., Charles Cohn, M.D., Prashanthi Giridhar, M.D., and Jonathan Kaufman, M.D.
  • Update on Medial Uses of Botulinum Toxin in Ophthalmology
    Kenn Freedman, M.D., Ph.D.
  • Evaluation and Management of Optic Disc Edema
    James Khu, M.D.
  • An Emerging Framework for Target Therapy of Uveal Melanoma
    David A. Lewis, M.D.
  • What’s New in Pediatric Ophthalmology?
    Curt Cockings, M.D.

The conference is sponsored by the TTUHSC Department of Ophthalmology and Visual Sciences and the Office of Continuing Medical Education. For more information, call Myra Jones, TTUHSC Office of Continuing Medical Education, at (806) 743-2929 or email myra.jones@ttuhsc.edu or cme@ttuhsc.edu

For more breaking news and experts, follow @ttuhscnews on Twitter.

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories

Education

Texas Tech University Health Sciences Center Names New School of Medicine Dean and Executive Vice President for Clinical Affairs

John C. DeToledo, M.D., has been named the TTUHSC School of Medicine dean and executive vice president for clinical affairs.

Education

Finding Purpose and Perspective in West Texas

Edgar Garza, second year student in the Master of Athletic Training program, spoke about his journey to TTUHSC and his hopes to shape the future of athletic training.

Research

Almodóvar Receives NIH Grant to Study Pulmonary Hypertension in HIV Patients

The National Heart, Lung and Blood Institute at the NIH recently awarded Sharilyn Almodóvar, Ph.D., a four-year, $2.67 million grant to study how the HIV virus damages the normal interactions between different cell types in the lung arteries that lead to the condition.